119th Congress Health
H.R. 1922: Ensuring Access to Essential Drugs Act
Introduced
- Introduced (completed)
- Passed House (not reached)
- Passed Senate (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
This bill exempts certain brand-name drugs from the Medicare Part D Manufacturer Discount Program. Under the program, drug manufacturers provide discounts to beneficiaries who have incurred costs above the annual deductible under the Medicare prescription drug benefit.
Specifically, the bill exempts from the program orally administered, brand-name drugs that are considered generics for purposes of the Medicaid Drug Rebate Program (per an exception granted by the Centers for Medicare & Medicaid Services).
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Cosponsors
- Diana Harshbarger R-TNOriginal
- Thomas Suozzi D-NYOriginal
Who scored on this bill
- 1Andrew Garbarino SponsorDrew cross-party cosponsors, introduced2 events+6
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Andrew Garbarino
- H.R. 9391: Reimbursable Screening Services Program Extension Act of 2026
- H.R. 4171: SEED Act of 2025
- H.R. 4130: Small Business Relief Act
- H.R. 5577: NFIP Extension Act of 2026
- H.R. 5061: Counter-UAS Authority Security, Safety, and Reauthorization Act
- H.R. 5079: Widespread Information Management for the Welfare of Infrastructure and Government Act
History
- Introduced in the House by Andrew Garbarino.
Show the full action history (2 actions)
- Introduced in House
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.